Evidence map›Paper›PMID 30747704›Full record

ArticleBlood transfusion = Trasfusione del sangue2019

Increase in post-reperfusion sensitivity to tissue plasminogen activator-mediated fibrinolysis during liver transplantation is associated with abnormal metabolic changes and increased blood product utilisation.

Hunter B Moore, Angelo D'Alessandro, Ernest E Moore, Matthew Wither, Peter J Lawson, Benjamin R Huebner, Kirk Hansen, Rashikh Choudhury, Trevor L Nydam

Abstract read
In one paragraph

Article in Blood transfusion = Trasfusione del sangue, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Personalised Transfusion Medicine.Blood transfusion = Trasfusione del sangue · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Hunter B MooreDepartments of Surgery, University of Colorado School of Medicine, Aurora, CO, United State of America.
Angelo D'AlessandroDepartment of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO, United State of America.
Ernest E MooreDepartments of Surgery, University of Colorado School of Medicine, Aurora, CO, United State of America.
Matthew WitherDepartment of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO, United State of America.
Peter J LawsonDepartments of Surgery, University of Colorado School of Medicine, Aurora, CO, United State of America.
Benjamin R HuebnerDepartments of Surgery, University of Colorado School of Medicine, Aurora, CO, United State of America.
Kirk HansenDepartment of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, CO, United State of America.
Rashikh ChoudhuryDepartments of Surgery, University of Colorado School of Medicine, Aurora, CO, United State of America.
Trevor L NydamDepartments of Surgery, University of Colorado School of Medicine, Aurora, CO, United State of America.
University of Colorado Denver · USDenver Health Medical Center · US

Funding

Analysis and Characterization of Trauma-Induced CoagulopathyUM1HL120877 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI MORRISSEY, JAMES H., WISNIEWSKI, STEPHEN R · 2013 to 2019
$26.6M
Mechanisms of Trauma-Induced CoagulopathyT32GM008315 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI Mitchell Cohen, ELIZABETH J. KOVACS · 1991 to 2026
$7.1M
NHLBI NIH HHS UM1 HL120877NIGMS NIH HHS T32 GM008315
6 · The paper itself

Abstract

backgroundIncreased systemic fibrinolytic activity can occur in liver transplant recipients after the donor graft is reperfused. However, it remains unclear whether this is related solely to tissue plasminogen activator (t-PA) levels or whether unique metabolic changes can alter t-PA activity and enhance fibrinolytic activity. We hypothesise that an increase in sensitivity to t-PA-mediated fibrinolysis (StF) following liver reperfusion is associated with specific metabolic abnormalities. MATERIALS AND

methodsLiver transplant recipients had serial blood samples analysed with a modified thrombelastography assay using exogenous t-PA to measure sensitivity/resistance to fibrinolysis with the lysis 30 min after maximum clot strength (tLY30). Paired plasma samples were analysed with mass spectroscopy-based metabolomics. The tLY30 was correlated to metabolites using Spearman's rho. StF was defined as a tLY30 change of >8.5% from the anhepatic phase to 30 min after reperfusion based on the distribution of tLY30 in a healthy control population.

resultsStF occurred in 53% of patients. Cohorts had similar MELD scores (18 vs 16, p=0.876) and tLY30 at baseline (p=0.867) and anhepatic phase of surgery (p=0.463). Thirty min after reperfusion, the tLY30 was 73% in patient with StF vs 33% in those without StF 33% (p=0.006). StF was associated with increased red blood cell transfusions (p=0.035), during the first 2 hours of reperfusion. Nine metabolites demonstrated a correlation with tLY30 (p<0.05). DISCUSSION: StF is a transient event that resolves within 2 hours of graft reperfusion and is associated with increased blood product use. This phenomenon correlates with derangements in citric acid cycle, purine and amino acid metabolism. Future research is needed to determine whether these metabolites are biomarkers or mechanistically linked to increased sensitivity to t-PA-mediated fibrinolytic activity following graft reperfusion.

Indexed as

FibrinolysisLiver TransplantationAdultAgedBlood TransfusionFemaleHumansMaleMetabolomicsMiddle AgedPlasminogen Activator Inhibitor 1Preoperative PeriodTissue Plasminogen ActivatorYoung AdultPlasminogen Activator Inhibitor 1PLAT protein, humanSERPINE1 protein, humanTissue Plasminogen Activator

Identifiers

PMID30747704
PMCPMC6683871
OpenAlexW2987427547

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.